Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine versus lidocaine nebulizer for attenuation of intubation pressor response in endoscopic nasal surgery
PACTR202611549871429Phase 2Completed
- Sponsor
- Saad Eldesoky Elzayat
- Start
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial comparing Intravenous dexmedetomidine with Lidocaine nebulizer (2 arms). Primary endpoint: Mean arterial blood pressure. Started Aug 2024; status: completed.
02
Drugs
dexmedetomidinelidocaine
Beyond the preview
Go deeper on PACTR202611549871429.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202611549871429.